PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2026Clinical Lymphoma Myeloma & LeukemiaOpen Access

Comparison of Patient-Reported Outcomes for Elranatamab in MagnetisMM-3 Versus Real-World Physician Choice of Therapy for Triple-Class Refractory Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBenjamin HébraudCCCharis CharalampousRPRicardo Parrondo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hébraud et al. (2026) studied this question.

synapsesocial.com/papers/6a1097fdd13714ec96001abchttps://doi.org/10.1016/j.clml.2026.03.014
View Full Paper
Ask AI
Bookmark
Share